{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:53:52Z","timestamp":1770234832709,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":1419,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["AI079217 (Y.X.)"],"award-info":[{"award-number":["AI079217 (Y.X.)"]}]},{"name":"NIH","award":["AI064537 (GMZ)"],"award-info":[{"award-number":["AI064537 (GMZ)"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.virol.2010.10.019","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T07:49:40Z","timestamp":1289288980000},"page":"271-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus"],"prefix":"10.1016","volume":"409","author":[{"given":"Xiangzhi","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youmin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Addie","family":"Embry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 11","key":"10.1016\/j.virol.2010.10.019_bb0005","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1099\/vir.0.008474-0","article-title":"Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein","volume":"90","author":"Adamo","year":"2009","journal-title":"J. Gen. Virol."},{"issue":"10","key":"10.1016\/j.virol.2010.10.019_bb0010","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/JVI.79.10.6260-6271.2005","article-title":"Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R","volume":"79","author":"Aldaz-Carroll","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2005.07.006","article-title":"Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene","volume":"341","author":"Aldaz-Carroll","year":"2005","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2010.10.019_bb0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"issue":"16","key":"10.1016\/j.virol.2010.10.019_bb0025","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.virol.2010.10.019_bb0030","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"Benhnia","year":"2008","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2010.10.019_bb0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.10.019_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0065-3527(06)66002-8","article-title":"In a nutshell: structure and assembly of the vaccinia virion","volume":"66","author":"Condit","year":"2006","journal-title":"Adv. Virus Res."},{"issue":"10","key":"10.1016\/j.virol.2010.10.019_bb0045","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2010.10.019_bb0050","unstructured":"Damon, I., 2007. Poxviruses. 5 ed. In \u201cFields Virology\u201d (D.M. Knipe, and P.M. Howley, Eds.), Vol. 2, pp. 2947\u20132976. 2 vols. Lippincott Williams & Wilkins, Philadelphia."},{"issue":"3","key":"10.1016\/j.virol.2010.10.019_bb0055","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.virol.2010.10.019_bb0060","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2010.10.019_bb0065","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"Davies","year":"2007","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/j.virol.2010.10.019_bb0070","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/JVI.01706-07","article-title":"Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax","volume":"82","author":"Davies","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.10.019_bb0075","series-title":"Current Protocols in Molecular Biology","first-page":"16.17.1","article-title":"Generation of recombinant vaccinia viruses","author":"Earl","year":"1998"},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2010.10.019_bb0085","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.virol.2010.10.019_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.virol.2010.10.019_bb0095","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0042-6822(88)90240-1","article-title":"Epitope mosaic on the surface proteins of orthopoxviruses","volume":"163","author":"Ichihashi","year":"1988","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2010.10.019_bb0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/viro.1996.0337","article-title":"Neutralizing epitope on penetration protein of vaccinia virus","volume":"220","author":"Ichihashi","year":"1996","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virol.2005.08.008","article-title":"Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin","volume":"343","author":"Jones-Trower","year":"2005","journal-title":"Virology"},{"issue":"6186","key":"10.1016\/j.virol.2010.10.019_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/335176a0","article-title":"Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins","volume":"335","author":"Kotwal","year":"1988","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.virol.2010.10.019_bb0120","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.4049\/jimmunol.176.6.3725","article-title":"Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation","volume":"176","author":"Liszewski","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.virol.2010.10.019_bb0125","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.4049\/jimmunol.0901366","article-title":"Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity","volume":"183","author":"Liszewski","year":"2009","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.virol.2010.10.019_bb0130","doi-asserted-by":"crossref","first-page":"10535","DOI":"10.1128\/JVI.74.22.10535-10550.2000","article-title":"Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon","volume":"74","author":"Lorenzo","year":"2000","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.virol.2010.10.019_bb0135","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.virol.2006.05.032","article-title":"Vaccinia virus K1L protein supports viral replication in human and rabbit cells through a cell-type-specific set of its ankyrin repeat residues that are distinct from its binding site for ACAP2","volume":"353","author":"Meng","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2010.10.019_bb0145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.virol.2007.10.023","article-title":"Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L","volume":"372","author":"Meng","year":"2008","journal-title":"Virology"},{"issue":"16","key":"10.1016\/j.virol.2010.10.019_bb0150","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1128\/JVI.77.16.8857-8871.2003","article-title":"Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane","volume":"77","author":"Mercer","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2010.10.019_bb0155","unstructured":"Moss, B., 2007. Poxviridae: the viruses and their replication. In \u201cFields Virology\u201d (D.M. Knipe, and P.M. Howley, Eds.), Vol. 2, pp. 2905\u20132946. 2 vols. Lippincott Williams & Wilkins, Philadelphia."},{"issue":"7","key":"10.1016\/j.virol.2010.10.019_bb0160","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.virol.2010.10.019_bb0165","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2008.08.009","article-title":"Vaccinia virus entry\/fusion complex subunit A28 is a target of neutralizing and protective antibodies","volume":"380","author":"Nelson","year":"2008","journal-title":"Virology"},{"issue":"39","key":"10.1016\/j.virol.2010.10.019_bb0170","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0506768102","article-title":"HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation","volume":"102","author":"Oseroff","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.icb.7100118","article-title":"Correlates of protective immunity in poxvirus infection: where does antibody stand?","volume":"86","author":"Panchanathan","year":"2008","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/jvi.31.1.147-155.1979","article-title":"Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus","volume":"31","author":"Payne","year":"1979","journal-title":"J. Virol."},{"issue":"Pt 11","key":"10.1016\/j.virol.2010.10.019_bb0185","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1099\/vir.0.81265-0","article-title":"Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy","volume":"86","author":"Putz","year":"2005","journal-title":"J. Gen. Virol."},{"issue":"11","key":"10.1016\/j.virol.2010.10.019_bb0190","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Putz","year":"2006","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.virol.2010.10.019_bb0195","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/jvi.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2010.10.019_bb0200","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/JVI.72.5.4192-4204.1998","article-title":"The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus","volume":"72","author":"Roper","year":"1998","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2010.10.019_bb0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2010.10.019_bb0210","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2008.04.018","article-title":"Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities","volume":"28","author":"Sette","year":"2008","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0042-6822(81)90653-X","article-title":"Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules","volume":"111","author":"Shida","year":"1981","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.virol.2010.10.019_bb0220","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.virol.2010.10.019_bb0230","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1128\/JVI.00427-06","article-title":"Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB\/c mice","volume":"80","author":"Tscharke","year":"2006","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2010.10.019_bb0235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0042-6822(91)90976-I","article-title":"The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: a degenerate conserved cleavage motif within core proteins","volume":"183","author":"Vanslyke","year":"1991","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2010.10.019_bb0240","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.micinf.2005.02.004","article-title":"Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees","volume":"7","author":"Viner","year":"2005","journal-title":"Microbes Infect."},{"issue":"15","key":"10.1016\/j.virol.2010.10.019_bb0245","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1073\/pnas.92.15.6773","article-title":"Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells","volume":"92","author":"Ward","year":"1995","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0042-6822(86)90405-8","article-title":"Identification of antigenic determinants by polyclonal and hybridoma antibodies induced during the course of infection by vaccinia virus","volume":"148","author":"Wilton","year":"1986","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2010.10.019_bb0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"issue":"25","key":"10.1016\/j.virol.2010.10.019_bb0260","doi-asserted-by":"crossref","first-page":"13856","DOI":"10.1073\/pnas.94.25.13856","article-title":"Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein","volume":"94","author":"Zhong","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682210006665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682210006665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:09:26Z","timestamp":1758586166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682210006665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0042682210006665"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2010.10.019","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2010.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}